title: [Clinico-morphologic evaluation of susceptibility of glioblastoma to antiblastic therapy].
abstract: Pathomorphology of a cerebral glioblastoma in 82 patients was studied. The most pronounced regressive changes in the glioblastoma occurred under the influence of a complex of antiblastic treatment, including polychemo- and immunotherapy, radiation therapy. A high degree of damaging effect on a glioblastoma tissue correlated with the longest lifetime of the patients--(22.8 +/- 2.6) mos. Of these patients, 26% survived more than 24 mos, 17%--more than 36 mos. In patients with chemo-resistant glioblastoma which retains morphologically a stability of its histologic structure, the mean survival almost didn't differ from that in the control group. Only few patients survived more than 1 year.
authors.forename: V M
authors.initials: VM
authors.lastname: Semenova
authors.forename: A Ia
authors.initials: AIa
authors.lastname: Glavatskiĭ
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D003131:Combined Modality Therapy; D005910:Glioma / Q000401:mortality / Q000473:pathology* / Q000628:therapy*; D006801:Humans; D015996:Survival Rate; D016896:Treatment Outcome
vernacular_title: Kliniko-morfologicheskaia otsenka chuvstvitelńosti glioblastomy k antiblasticheskoĭ terapii.